These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9334885)

  • 1. Pharmacological studies on the novel antiallergic agent HSR-609: its effects on behavior in mice and electroencephalograms in rabbits.
    Kakiuchi M; Ohashi T; Tanaka K; Kamiyama K; Morikawa K; Kato H
    Jpn J Pharmacol; 1997 Sep; 75(1):43-57. PubMed ID: 9334885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system effects of the novel antiallergic agent HSR-609 and typical antiallergic agents using behavioral and electroencephalographic analyses in dogs.
    Kakiuchi M; Ohashi T; Tanaka K; Ohara N; Kamiyama K; Morikawa K; Kato H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Oct; 18(5):189-99. PubMed ID: 10028490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
    Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
    Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphoteric drugs. 3. Synthesis and antiallergic activity of 3-[(5,11-dihydro[1]benzoxepino[4,3-b]pyridin-11- ylidene)piperidino]propionic acid derivatives and related compounds.
    Iwasaki N; Ohashi T; Musoh K; Nishino H; Kado N; Yasuda S; Kato H; Ito Y
    J Med Chem; 1995 Feb; 38(3):496-507. PubMed ID: 7853343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an amphoteric antiallergic agent, HSR-609, on antigen-induced late phase nasal eosinophilia in brown Norway rats.
    Musoh K; Nakamura N; Nagai H
    Pharmacology; 2000 Nov; 61(4):230-7. PubMed ID: 11093074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.
    Kato M; Nishida A; Aga Y; Kita J; Kudo Y; Narita H; Endo T
    Arzneimittelforschung; 1997 Oct; 47(10):1116-24. PubMed ID: 9368705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
    Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S
    Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (5) Action of M73101 on the central nervous system (author's transl)].
    Sato M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):695-706. PubMed ID: 575516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 2nd communication: Effects on central nervous and sensory systems and on the other functions.
    Matsuno Y; Hori H; Oka M; Nakamura H; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):62-8. PubMed ID: 3513778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphoteric drugs. I. Synthesis and antiallergic activity of [4-(diphenylmethoxy)piperidino]-, [4-(diphenylmethyl)piperazinyl]- and [4-(diphenylmethylene)piperidino]alkanoic acid derivatives.
    Iwasaki N; Sakaguchi J; Ohashi T; Takahara E; Ogawa N; Yasuda S; Koshinaka E; Kato H; Ito Y; Sawanishi H
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2276-84. PubMed ID: 7859328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S; Toba Y; Suzuki S; Ninomiya S; Umezato M; Hiyama T
    Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and neuropharmacology of cyclopiazonic acid.
    Nishie K; Cole RJ; Dorner JW
    Food Chem Toxicol; 1985 Sep; 23(9):831-9. PubMed ID: 4043883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a novel anti-allergic agent, HSR-609, on antigen-induced airway hyperresponsiveness in mice.
    Musoh K; Maeda Y; Tanaka H; Inagaki N; Nagai H
    Pharmacology; 2000 Aug; 61(2):70-7. PubMed ID: 10940779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice.
    Librowski T; Czarnecki R; Mendyk A; Jastrzebska M
    Pol J Pharmacol; 2000; 52(4):317-21. PubMed ID: 11345489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Natulan (procarbazine hydrochloride) on the central nervous system].
    Furukawa T; Ono N; Hanabusa Y; Kushiku K
    Nihon Yakurigaku Zasshi; 1971; 67(3):220-30. PubMed ID: 5105249
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibitory effects of methyl o-(4-hydroxy-3-methoxycinnamoyl) reserpate (CD-3400) on the central nervous system (author's transl)].
    Shika K; Nakata C; Ogura M; Tamada T; Fujimoto Y
    Nihon Yakurigaku Zasshi; 1977 Oct; 73(7):717-34. PubMed ID: 23346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.
    Hardman HF; Domino EF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):295-315. PubMed ID: 5002533
    [No Abstract]   [Full Text] [Related]  

  • 19. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.